Liisa Sailas

Joensuu, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

KaSARi: a national framework for standardized, automated, and predictive radiotherapy in Finland.

KaSARi: a national framework for standardized, automated, and predictive radiotherapy in Finland.

Journal: Acta oncologica (Stockholm, Sweden)

Published: March 10, 2026

Distinct roles of WHO Score, CCI, and CFS in prognosis and treatment decisions for non-small cell lung cancer: A retrospective real-world study.

Distinct roles of WHO Score, CCI, and CFS in prognosis and treatment decisions for non-small cell lung cancer: A retrospective real-world study.

Journal: Cancer treatment and research communications

Published: October 02, 2025

Impact of Treatment Decisions on Survival Outcomes in Elderly Patients With Non-Small Cell Lung Cancer: A Retrospective Real-World Study.

Impact of Treatment Decisions on Survival Outcomes in Elderly Patients With Non-Small Cell Lung Cancer: A Retrospective Real-World Study.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: April 26, 2025

Outcome of lung cancer surgery and proportion of lung cancer patients eligible for surgery in five Finnish hospitals in 2018, real world study.

Outcome of lung cancer surgery and proportion of lung cancer patients eligible for surgery in five Finnish hospitals in 2018, real world study.

Journal: Acta oncologica (Stockholm, Sweden)

Published: March 18, 2025

Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for ERBB2-Positive Breast Cancer: A Secondary Analysis of the SOLD Randomized Clinical Trial.

Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for ERBB2-Positive Breast Cancer: A Secondary Analysis of the SOLD Randomized Clinical Trial.

Journal: JAMA network open

Published: August 26, 2024

Changes in the use of chemoradiotherapy for non-small cell lung cancer after guideline implementation in Finland between 2016 and 2020.

Changes in the use of chemoradiotherapy for non-small cell lung cancer after guideline implementation in Finland between 2016 and 2020.

Journal: Cancer treatment and research communications

Published: July 08, 2024

A David and Goliath set-up: a qualitative study of the challenges of ensuring the introduction of cost-effective new cancer medicines in Finland.

A David and Goliath set-up: a qualitative study of the challenges of ensuring the introduction of cost-effective new cancer medicines in Finland.

Journal: Journal of pharmaceutical policy and practice

Published: June 02, 2022

Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The SOLD Randomized Clinical Trial.

Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The SOLD Randomized Clinical Trial.

Journal: JAMA oncology

Published: June 01, 2018

Hypofractionated stereotactic body radiotherapy for localized prostate cancer - first Nordic clinical experience.

Hypofractionated stereotactic body radiotherapy for localized prostate cancer - first Nordic clinical experience.

Journal: Acta oncologica (Stockholm, Sweden)

Published: May 19, 2017

Dosimetric Comparison and Evaluation of 4 Stereotactic Body Radiotherapy Techniques for the Treatment of Prostate Cancer.

Dosimetric Comparison and Evaluation of 4 Stereotactic Body Radiotherapy Techniques for the Treatment of Prostate Cancer.

Journal: Technology in cancer research & treatment

Published: March 11, 2017

Stereotactic radiotherapy is established treatment in localized non-small cell lung cancer

Stereotactic radiotherapy is established treatment in localized non-small cell lung cancer

Journal: Duodecim; laaketieteellinen aikakauskirja

Published: May 03, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026